πŸ‡ΊπŸ‡Έ FDA
Patent

US 9540380

Imidazotriazinone compounds

granted A61PA61P21/00A61P25/00

Quick answer

US patent 9540380 (Imidazotriazinone compounds) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P21/00, A61P25/00, A61P25/14, A61P25/16